High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Min, Kyueng-Whan | - |
dc.contributor.author | Kim, Dong-Hoon | - |
dc.contributor.author | Do, Sung-Im | - |
dc.contributor.author | Pyo, Jung-Soo | - |
dc.contributor.author | Chae, Seoung Wan | - |
dc.contributor.author | Sohn, Jin Hee | - |
dc.contributor.author | Kim, Kyungeun | - |
dc.contributor.author | Lee, Hyun Joo | - |
dc.contributor.author | Kim, Dong Hyun | - |
dc.contributor.author | Oh, Sukjoong | - |
dc.contributor.author | Choi, Seon Hyeong | - |
dc.contributor.author | Park, Yong Lai | - |
dc.contributor.author | Park, Chan Heun | - |
dc.contributor.author | Kwon, Mi Jung | - |
dc.contributor.author | Moon, Kyoung Min | - |
dc.date.accessioned | 2022-07-14T23:57:12Z | - |
dc.date.available | 2022-07-14T23:57:12Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2016-12 | - |
dc.identifier.issn | 0032-5473 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153417 | - |
dc.description.abstract | Aims Breast cancers are heterogeneous, making it essential to recognise several biomarkers for cancer outcome predictions. Ki67 proliferation index and B cell lymphoma 2 (BCL2) proteins are widely used as prognostic indicators in many types of malignancies. While Ki67 is a marker of normal or tumour cell proliferation, BCL2 plays a central role in antiproliferative activities. A combination of these two biomarkers with contrary purposes can provide enhanced prognostic accuracy than an analysis using a single biomarker. Methods We evaluated Ki67 and BCL2 expression with 203 cases of breast cancer. The relative expression of each biomarker named as Ki67/BCL2 index was divided into two groups (low vs high) with the use of area under receiver operating characteristic curves. Results There were significant correlations between Ki67/BCL2 index and clinicopathological findings such as age, tumour stage, size and necrosis, histological grade, extensive intraductal component, lymphatic and vascular invasion, oestrogen receptor, progesterone receptor, human epithelial growth factor receptor 2 and p53 expression (all p<0.05). In univariate and multivariate analyses, high Ki67/BCL2 index correlated with shorter disease-free survival and overall survival in patients with early stage invasive ductal carcinoma (all p< 0.05). Conclusions The Ki67/BCL2 index should be considered as a prognostic predictor in patients with early stage invasive ductal carcinoma. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMJ PUBLISHING GROUP | - |
dc.title | High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Min, Kyueng-Whan | - |
dc.identifier.doi | 10.1136/postgradmedj-2015-133531 | - |
dc.identifier.scopusid | 2-s2.0-84973320464 | - |
dc.identifier.wosid | 000389209500004 | - |
dc.identifier.bibliographicCitation | POSTGRADUATE MEDICAL JOURNAL, v.92, no.1094, pp.707 - 714 | - |
dc.relation.isPartOf | POSTGRADUATE MEDICAL JOURNAL | - |
dc.citation.title | POSTGRADUATE MEDICAL JOURNAL | - |
dc.citation.volume | 92 | - |
dc.citation.number | 1094 | - |
dc.citation.startPage | 707 | - |
dc.citation.endPage | 714 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | PROGRAMMED CELL-DEATH | - |
dc.subject.keywordPlus | BCL-2 EXPRESSION | - |
dc.subject.keywordPlus | GUIDELINE RECOMMENDATIONS | - |
dc.subject.keywordPlus | PROGNOSTIC-SIGNIFICANCE | - |
dc.subject.keywordPlus | PRIMARY CHEMOTHERAPY | - |
dc.subject.keywordPlus | ESTROGEN-RECEPTORS | - |
dc.subject.keywordPlus | AMERICAN SOCIETY | - |
dc.subject.keywordPlus | PATIENT SURVIVAL | - |
dc.subject.keywordPlus | GRADING SYSTEM | - |
dc.subject.keywordPlus | P53 EXPRESSION | - |
dc.identifier.url | https://pmj.bmj.com/content/92/1094/707 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.